Ovarian Function Suppression May Benefit Select Breast Cancer PopulationsBySung Gwe Ahn, MD, PhDSeptember 22nd 2024Patients with HR-positive, HER2-positive breast cancer and high-risk features may derive benefit from ovarian function suppression plus endocrine therapy.